Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Epstein-Barr virus]

J C Nicolas1, V Maréchal, A Dehée

  • 1Service de Microbiologie, Hôpital Rothschild, Paris.

Bulletin De L'Academie Nationale De Medecine
|June 1, 1997
PubMed
Summary
This summary is machine-generated.

Epstein-Barr virus (EBV) causes infectious mononucleosis and is linked to cancers. Molecular diagnostics aid in understanding EBV

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Spontaneous resolution of foveoschisis secondary to intravitreal ranibizumab injection for myopic choroidal neovascularization].

Journal francais d'ophtalmologie·2025
Same author

Medecine et maladies infectieuses·2024
Same author

Highly efficient and sensitive membrane-based concentration process allows quantification, surveillance, and sequencing of viruses in large volumes of wastewater.

Water research·2023
Same author

[The French Armed Forces Biomedical Research Institute (IRBA) and wastewater-based epidemiology: Applicability and relevance in armed forces].

Bulletin de l'Academie nationale de medecine·2023
Same author

SARS-CoV-2 genome quantification in wastewaters at regional and city scale allows precise monitoring of the whole outbreaks dynamics and variants spreading in the population.

The Science of the total environment·2021
Same author

Several forms of SARS-CoV-2 RNA can be detected in wastewaters: Implication for wastewater-based epidemiology and risk assessment.

Water research·2021
Same journal

[Advances and perspectives in vascularized composite allotransplantation preservation].

Bulletin de l'Academie nationale de medecine·2025
Same journal

[COVID-19: Neurological manifestations and complications during the acute phase of the disease].

Bulletin de l'Academie nationale de medecine·2024
Same journal

[Role of psychological factors in post-COVID-19 condition].

Bulletin de l'Academie nationale de medecine·2023
Same journal

[From the origin of Sars-CoV-2 to dangerous virology/biology].

Bulletin de l'Academie nationale de medecine·2023
Same journal

[Neurological forms of long COVID in adults: Critical approach].

Bulletin de l'Academie nationale de medecine·2023
Same journal

[Post-COVID-19 syndrome].

Bulletin de l'Academie nationale de medecine·2023
See all related articles

Area of Science:

  • Virology
  • Immunology
  • Oncology

Context:

  • Epstein-Barr virus (EBV), a human herpesvirus, establishes lifelong latent infections.
  • EBV is globally prevalent, with most individuals infected.
  • It's associated with infectious mononucleosis and several cancers, including Burkitt's lymphoma and nasopharyngeal carcinoma.

Purpose:

  • To review the complex nature of EBV infection, including its latent and replicative cycles.
  • To describe the host immune response to EBV, encompassing humoral and cell-mediated immunity.
  • To highlight the role of molecular biology in diagnosing EBV and understanding its associated diseases.

Summary:

  • EBV infection involves latent periods in lymphoid cells and replication in epithelial cells.
  • The immune system mounts a response involving antibodies and cytotoxic T cells.

Related Experiment Videos

  • Molecular diagnostic techniques are crucial for identifying EBV and its role in diseases.

    • Impact:

    • Improved understanding of EBV pathogenesis and associated malignancies.
    • Advancements in diagnostic strategies for EBV-related disorders.
    • Potential for developing targeted therapies against EBV-driven diseases.